Lyon, France, December 4, 2018 – iDD biotech, a French immuno-oncology company with a large pipeline of preclinical and clinical stage monoclonal antibodies, reports ...

Following the news that Apple recently announced that 400,000 participants were enrolled in the Apple Heart trial, a study aimed at screening atrial fibrillation, She...

Hannover, Germany, December 03, 2018 / B3C newswire / -- Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced today that the f...

Patients with hereditary angioedema experience recurrent and sometimes life-threatening swelling attacks. Researchers from Charité - Universitätsmedizin Berlin have t...

The U.S. Food and Drug Administration approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the...

Confirmed clean safety profile No serious or severe adverse effects Primary endpoints of safety and pharmacokinetic data achieved Stevenage, UK, November 26, ...